Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE: Ranibizumab in Diabetic Macular Edema
NCT00284050Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2005
- Primary completion
- Jun 2008
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in diabetic macular edema (DME), sponsored by Novartis. Started Oct 2005; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00284050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284050.